The Federal program of cardiovascular diseases
The Federal program of cardiovascular diseases
Ang mga modernong gamot sa pag-imprenta ay hinahati sa 10 iba't ibang grupo ayon sa kanilang mekanismo ng pagkilos. Pagkatapos suriin ng doktor ang mga reklamo ng pasyente at ang resulta ng mga pagsusuri, nagrereseta siya ng isa o higit pang gamot, na hindi dapat baguhin nang mag-isa. Ang mga gamot sa puso at daluyan ng dugo ay hindi kabilang sa mga puwedeng irekomenda sa kaibigan. Ang maling desisyon ay maaaring magdulot ng malungkot na kahihinatnan. Lahat ng gamot na pampababa ng presyon ng dugo ay kailangan ng reseta. Sa artikulong ito, tinitingnan natin ang kanilang modernong klasipikasyon base sa mga aktibong sangkap at sa paraan ng epekto nito sa katawan.
>>> ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ <<<
The Federal program for the prevention and control of cardiovascular diseases in Germany Cardiovascular disease (CVD) is one of the most important health challenges in Germany. According to statistics from the Robert Koch‑Institute of thousands of deaths, and go back a year, to diseases of the cardiovascular system, which makes it one of the leading causes of death. Against this Background, initiated at the Federal level, a comprehensive program for the prevention and control of these diseases. Objectives of the Federal program The main focus of the Federal programme on the reduction of the incidence and prevalence of cardiovascular diseases through a combination of primary, secondary and tertiary prevention. Specific objectives include: Reduction in the average blood pressure values in the population; Reduction in the proportion Smoking adult by at least 15% within five years; Increase the physical activity of the population, particularly in urban areas; Improve the eating habits through awareness-raising for a healthy diet; Early diagnosis and effective long-term management of high-risk patients. Measures and strategies The program relies on a variety of measures that can be implemented at different levels: Public awareness campaigns Through media campaigns and local events is Smoking the population about risk factors (e.g., hypertension, Diabetes, Obesity, lack of physical activity), and preventive measures. Promoting healthy lifestyles: initiatives for the creation of sports facilities (e.g., bike paths, fitness trails in Parks), education programs for a healthy diet and anti-Smoking campaigns. The improvement of medical care: introduction of standardized Screening programs for at-risk groups, training of Physicians in early diagnosis and multimodal therapy, the development of specialist centres for cardiovascular diseases. Research and data collection support from epidemiological studies for the analysis of Trends and risk factors, development of a national register of cardiovascular diseases for the optimization of supply structures. Cooperation with municipalities and organizations: partnerships with local health departments, sports nutrition organizations and health insurance companies, clubs, and the implementation of local prevention programs. Implementation and funding The implementation of the programme is carried out in close cooperation between the Federal Ministry of health, the States, local authorities, health insurance companies, and civil society organisations. The funding is provided from the funds of the Federal budget, supplemented by contributions from the health insurance companies and third-party funding of research programs. The first interim results and prospects After the first three years of implementation of the evaluation reports show a slight decrease in the average blood pressure values and an increase in participation in sport. At the same time the proportion of smokers remains in some groups of the population, which implies a far-reaching measures. The long-term strategy is to consolidate the achievements through continuous adjustment of the measures, and greater involvement of at-risk groups (e.g. low socio-economic level), and expand. Conclusion The Federal programme for the control of cardiovascular diseases is an important step to improve public health in Germany. Through a combined strategy of awareness, prevention, early diagnostics and research, the load can be reduced by these diseases in a sustainable way. The close cooperation of all stakeholders is the key to success.
Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas. The Federal program of cardiovascular diseases. If you have disturbed sleep, fatigue, disorientation, confusion, or nervousness, it's time to monitor your blood pressure. Either lack of sleep or too much sleeping might mean your blood pressure is high or low. If it’s left untreated, you will soon face an onslaught of multiple illnesses.
Exercises against high blood pressure Dr Video
Cardiovascular Disease Nizhny Novgorod
Tablets of high blood pressure
Varicose veins is a disease of the cardiovascular System
http://donfon.ru/posts/12550-cardiovascular-disease-processes.html
http://orunikat.beget.tech/articles/49606-analyses-in-cardiovascular-diseases.html
People have long used Hawthorne berries for treating high bp, heart issues, and cholesterol levels. A number of Clinical research conclude that it improves cardiovascular function, shortness of breath, and fatigue. In another study, 1200 mg hawthorn extract or placebo was taken by hypertension patients for 16 weeks. Those who were taking hawthorn extract had a significant decrease in blood pressure than the other group taking a placebo. Isang malawak na pagpipilian ng mga gamot mismo pati na rin ng mga pamamaraan para sa pagbawas ng gamot mula sa mataas na presyon ang nagbibigay-daan sa iyo na pumili ng pinaka-komportableng programa ng paggamot – ang abot-kaya sa gastos, na may minimal na pagpapakita ng mga side effect, at isinasaalang-alang ang ibang kasamang sakit. Kapag matagal ang pag-inom ng tabletas at binabago ng doktor ang gamot, ito ay dahil ang ilang gamot ay may katangian na magdulot ng pagkagumon, na nagreresulta sa kaunting pagbaba ng bisa nito. Bukod dito, hindi lahat ng grupo ng gamot ay angkop para sa mga pasyente sa iba't ibang edad, at may mga limitasyon din sa pagiging compatible nito sa ibang uri ng gamot.